Tissue engineered vascular grafts: current state of the field

Chin Siang Ong, Xun Zhou, Chen Yu Huang, Takuma Fukunishi, Huaitao Zhang, Narutoshi Hibino

研究成果: Review article同行評審

30 引文 斯高帕斯(Scopus)


Introduction: Conventional synthetic vascular grafts are limited by the inability to remodel, as well as issues of patency at smaller diameters. Tissue-engineered vascular grafts (TEVGs), constructed from biologically active cells and biodegradable scaffolds have the potential to overcome these limitations, and provide growth capacity and self-repair. Areas covered: This article outlines the TEVG design, biodegradable scaffolds, TEVG fabrication methods, cell seeding, drug delivery, strategies to reduce wait times, clinical trials, as well as a 5-year view with expert commentary. Expert commentary: TEVG technology has progressed significantly with advances in scaffold material and design, graft design, cell seeding and drug delivery. Strategies have been put in place to reduce wait times and improve ‘off-the-shelf’ capability of TEVGs. More recently, clinical trials have been conducted to investigate the clinical applications of TEVGs.

頁(從 - 到)383-392
期刊Expert Review of Medical Devices
出版狀態Published - 2017 五月 4

All Science Journal Classification (ASJC) codes

  • Surgery
  • Biomedical Engineering

指紋 深入研究「Tissue engineered vascular grafts: current state of the field」主題。共同形成了獨特的指紋。